What is the equity of Cann Group this year?
Cann Group has equity of 59.26 M AUD this year.
Cann Group Equity 2024
Cann Group Equity
59.26 M AUD
Ticker
CAN.AX
ISIN
AU000000CAN2
WKN
A2DSUQ
In 2024, Cann Group's equity was 59.26 M AUD, a -30.2% increase from the 84.9 M AUD equity in the previous year.
Cann Group Aktienanalyse
What does Cann Group do?
Cann Group Ltd is an Australian company specializing in the production and marketing of medical cannabis. The company was founded in 2013 and is headquartered in Melbourne. The company's history began with the founding of an independent consulting firm called AusCann Group Holdings Ltd in 2014. This firm was created to inform Australian and international investors about the opportunities and possibilities in the Australian cannabis market. In 2016, a cooperation agreement was signed between AusCann and Cann Group Ltd to advance the cultivation and production of medical cannabis products in Australia. Since then, Cann Group has continuously invested in the development and growth of the Australian medical cannabis market. The company has obtained a Good Manufacturing Practices (GMP) compliance license to ensure that all products meet the highest quality and safety standards. This includes collaborating with research institutions and state health authorities to investigate the efficacy and safety of medications. Cann Group's various business areas include the production of medical cannabis, research, product development, and marketing. The company operates a cannabis cultivation facility in Cochranes Hill, Victoria, covering an area of 20 hectares. The cultivation of cannabis is carried out under controlled conditions to ensure that all products are of the highest quality and purity. The cultivated cannabis is then used to manufacture medical products such as oils, tinctures, capsules, and sprays. Cann Group also collaborates closely with research institutions and academic institutions to study the safety and efficacy of medical cannabis. The company has partnerships with the University of Melbourne, Queensland University of Technology, and Swinburne University of Technology for research on the mechanisms of cannabis, application research, and studies on the clinical efficacy of cannabis. The business model of Cann Group is based on the sale of medical cannabis products to pharmacies and medical facilities in Australia and worldwide. The company, through its license, is one of the few companies capable of producing and exporting medical cannabis for the Australian market. In addition to exporting cannabis products to Germany, New Zealand, the UK, and other countries, the sale of cannabis products to the Australian market is the largest market for Cann Group. The company offers a variety of medical cannabis products specifically developed for various medical conditions. These include products for anxiety, nausea and vomiting, pain, seizures, and many other diseases. There are also products for palliative care, which help alleviate pain and suffering in the final stages. Overall, Cann Group Ltd has played a pioneering role in the development of the Australian medical cannabis market in recent years. The company specializes in the production of medical cannabis products that meet the highest quality standards and strict regulatory requirements. The company is committed to improving the therapeutic approach to diseases and enhancing the quality of life for patients. Cann Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Cann Group's Equity
Cann Group's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Cann Group's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Cann Group's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Cann Group's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Cann Group’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Cann Group stock
What was the equity of Cann Group compared to the previous year?
The equity of Cann Group has increased/decreased by -30.2% decreased compared to the previous year.
What impact does a high equity have on investors of Cann Group?
A high equity is advantageous for investors of Cann Group as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Cann Group?
A low equity can be a risk for investors of Cann Group, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Cann Group affect the company?
An increase in equity of Cann Group can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Cann Group affect the company?
A reduction in equity of Cann Group can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Cann Group?
Some factors that can affect the equity of Cann Group include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Cann Group so important for investors?
The equity of Cann Group is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Cann Group take to change the equity?
To change equity, Cann Group can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Cann Group pay?
Over the past 12 months, Cann Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cann Group is expected to pay a dividend of 0 AUD.
What is the dividend yield of Cann Group?
The current dividend yield of Cann Group is .
When does Cann Group pay dividends?
Cann Group pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Cann Group?
Cann Group paid dividends every year for the past 0 years.
What is the dividend of Cann Group?
For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Cann Group located?
Cann Group is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cann Group kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cann Group from 9/11/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/11/2024.
When did Cann Group pay the last dividend?
The last dividend was paid out on 9/11/2024.
What was the dividend of Cann Group in the year 2023?
In the year 2023, Cann Group distributed 0 AUD as dividends.
In which currency does Cann Group pay out the dividend?
The dividends of Cann Group are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cann Group
Our stock analysis for Cann Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cann Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
